see more

NEW YORK, NY - DECEMBER 17: Martin Shkreli (2nd R), CEO of Turing Pharmaceutical, is brought out of 26 Federal Plaza by law enforcement officials after being arrested for securities fraud on December 17, 2015 in New York City. Shkreli gained notoriety earlier this year for raising the price of Daraprim, a medicine used to treat the parasitic condition of toxoplasmosis, from $13.50 to $750 though the arrest that happened early this morning does not involve that price hike. (Photo by Andrew Burton/Getty Images)

NEW YORK, NY - DECEMBER 17: Martin Shkreli (2nd R), CEO of Turing Pharmaceutical, is brought out of 26 Federal Plaza by law enforcement officials after being arrested for securities fraud on December 17, 2015 in New York City. Shkreli gained notoriety earlier this year for raising the price of Daraprim, a medicine used to treat the parasitic condition of toxoplasmosis, from $13.50 to $750 though the arrest that happened early this morning does not involve that price hike. (Photo by Andrew Burton/Getty Images)
Getty Images

Getty Images News Andrew Burton

see more

NEW YORK, NY - JUNE 6: (L to R) Attorney Benjamin Brafman and ex-pharmaceutical executive Martin Shkreli exit the U.S. District Court for the Eastern District of New York, June 6, 2016, in the Brooklyn borough of New York City. Federal prosecutors filed new criminal charges accusing Shkreli of more illegal financial maneuvers at his former drug company Retrophin Inc. (Photo by Drew Angerer/Getty Images)

NEW YORK, NY - JUNE 6: (L to R) Attorney Benjamin Brafman and ex-pharmaceutical executive Martin Shkreli exit the U.S. District Court for the Eastern District of New York, June 6, 2016, in the Brooklyn borough of New York City. Federal prosecutors filed new criminal charges accusing Shkreli of more illegal financial maneuvers at his former drug company Retrophin Inc. (Photo by Drew Angerer/Getty Images)
Getty Images

Getty Images News Drew Angerer